What is AtriCure's SG&A?

AtriCure (ATRC) reported SG&A of $82.56M in Q2 2026.

How has AtriCure's SG&A changed year-over-year?

AtriCure's SG&A increased by 5.3% year-over-year, from $78.39M to $82.56M.

What is the long-term trend for AtriCure's SG&A?

Over 4 years (2021 to 2025), AtriCure's SG&A has grown at a 10.3% compound annual growth rate (CAGR), from $209.75M to $311.02M.

Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.

AtriCure ATRC SG&A

Discontinued — last reported Q2 '26

SG&A at other companies

AbbottABT

$4.03B+30.2%

Johnson & JohnsonJNJ

$6.43B+9.2%

Boston ScientificBSX

$1.8B+5.1%

MedtronicMDT

$3.06B+12.4%

Pulse Biosciences, Inc.PLSE

$6.59M-14.7%

ITG

Integer HoldingsITGR

$58.71M+14.8%

Other financials

Income statement

See full

Revenue$153.6M+12.8%

Gross profit$118.6M+16.9%

Operating income$9.7M+256%

Net income$9.0M+245%

EPS (diluted)$0.18+238%

Balance sheet

See full

Cash & equivalents$167.8M+42.4%

Total debt$75.5M-3.8%

Total equity$516.4M+11.2%

Total assets$676.6M+11.1%

Cash flow

See full

Operating cash flow$22.2M+2.7%

CapEx$3.8M+41.5%

Free cash flow$18.4M-2.8%

Valuation

See full

Market cap$1.89B+28.7%

Enterprise value$1.8B+26.0%

P/E726.2×—

P/S3.3×+0.4×

Profitability

See full

Gross margin76.3%+1.6pp

Operating margin-5.1%-1.3pp

Net margin-5.6%-1.5pp

FCF margin9.3%—

Returns & leverage

See full

Return on equity-6.1%-1.3pp

Debt / equity0.1×0.0×

Current ratio4.2×+0.3×

Where this comes from

Reported directly by AtriCure in its filing.

Tagged under the XBRL concept us-gaap:SellingGeneralAndAdministrativeExpense.

The official record: AtriCure’s 10-Q, filed July 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about AtriCure's sg&a.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is AtriCure's SG&A?: AtriCure (ATRC) reported SG&A of $82.56M in Q2 2026.
How has AtriCure's SG&A changed year-over-year?: AtriCure's SG&A increased by 5.3% year-over-year, from $78.39M to $82.56M.
What is the long-term trend for AtriCure's SG&A?: Over 4 years (2021 to 2025), AtriCure's SG&A has grown at a 10.3% compound annual growth rate (CAGR), from $209.75M to $311.02M.
What does SG&A mean?: Combined selling expenses (sales force, marketing, distribution) and general & administrative costs (management, legal, accounting, facilities) — the broadest opex category.